Doral, Florida Clinical Trials

A listing of Doral, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, …

Research Institute of South Florida- Site Number : 8400023
 (8.0 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +50 other locations
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal and genital) regions. This study will evaluate how well upadacitinib compared to placebo (no medicine) works to treat hidradenitis suppurativa (HS) in adult participants with moderate to severe disease. …

Lakes Research, LLC /ID# 218854
 (7.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +27 other locations
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

lower respiratory tract infection
syphilis test
antigen test
hepatitis b
prenatal
North Shore Medical Center
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +155 other locations
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of CT1812 in adults with mild to moderate Alzheimer's Disease (AD).

Allied Biomedical Research Institute
 (6.2 away) Contact site
  • 0 views
  • 20 Sep, 2024
  • +10 other locations
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

This trial will evaluate the safety, efficacy, pharmacokinetics, fecal concentrations, and fecal microbiome effects of ACX-362E [ibezapolstat] in patients with C. difficile infection (CDI). The current record applies only to Segment 2A, primary completion date August 2020.

white blood cell count
aspart
stool test
diarrhea
Acurx Site #105
 (2.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Study of Single-dose DS-3201b in Participants With Hepatic Impairment

This is a Phase 1, open-label, parallel design, single-dose pharmacokinetic (PK) study to assess the safety, tolerability, and PK of a single dose of 50 mg of DS-3201b in participants with normal and impaired hepatic function.

liver disease
gilbert's syndrome
vasectomy
hepatic impairment
drug tests
Clinical Pharmacology of Miami, LLC
 (7.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Baby Item Learning and Development Study

The goal of this study is to experimentally test whether baby items can promote healthy infant development.

University of Miami
 (8.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

This is a phase 1, open label, single arm study in which ARQ-151 cream 0.3% is applied QD for 2 weeks to adolescent subjects with chronic plaque psoriasis involving at least 10% body surface area (BSA) and adult subjects with chronic plaque psoriasis involving at least 20% BSA (excluding scalp). …

12 lead electrocardiogram
electrocardiogram
psoriasis vulgaris
psoriasis
serum pregnancy test
Arcutis Clinical Site 03
 (2.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis

Premier Clinical Research Institute, Inc.
 (2.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +18 other locations
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

University of Miami Miller School of Medicine
 (9.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations